Pyxis Oncology (PYXS) Net earnings per share growth forecast for next year

Symbol and logo of brand Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology, Inc. (PYXS) is developing a comprehensive environment for targeted tumor treatment by integrating antibody platforms. A promising growth vector for EPS estimates confirms this potential, with the indicator reaching 25.60. High demand for the elimination of cancer stroma ensures future pricing power, although it is currently obscured by a lack of sales and dependence on clinical trial outcomes.

PYXS - Pyxis Earnings growth forecast for next year over the range 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for Pyxis Oncology, Inc. (PYXS)

- price and consensus price forecast:
Analysis of all company metrics:Pyxis Oncology, Inc.
Core merchandise of Pyxis

This indicator reflects the analysts' consensus forecast for the change in earnings per share for the next financial period. Investors utilize the modeled EPS growth for the upcoming fiscal year to assess the future value of the business and minimize the risk of overpaying. Positive momentum confirms market optimism regarding the commercialization of developments. This is critical for Pyxis Oncology, Inc. (PYXS), as the approval of targeted cancer therapy would ensure a sharp surge in revenue with minimal costs.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year CGEN|Earnings growth forecast for next year IOBT (IO Biotech)|Expected earnings per share trend next year STRO|minktherapeutics.com - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics, Inc.|Immix (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Cue Biopharma|Earnings growth forecast for next year pdsbiotech.com|Net earnings per share growth forecast for next year sonnetbio.com (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Inc. - Expected earnings per share growth for next year|LAVA Therapeutics N.V. (LVTX) - Expected net earnings per share growth next year|NXTC - Net earnings per share growth forecast for next year|LPTX: Net earnings per share growth forecast for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year